Arkolith/Insider Trading/ABOS/Form 4

Meisner Derek M

Chief Legal Officer & Corp SecAcumen Pharmaceuticals, Inc. (ABOS) · full profile →Form 4 · filed Mar 10, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$7K
Net Open-Market Flow
-$7K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 6, 2026Option exercise(M)2K$1.85$4K176K
Mar 6, 2026Sell(S)2K$3.26$7K174K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 6, 2026Option exercise(M)2K—$071K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-26-016645) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML